A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)

Recruiting

Phase 2

GX-03A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)

Sponsor:

Turn Therapeutics

Code:

NCT07355075

Conditions

Eczema Atopic Dermatitis

Eczema

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

GX-03

Vehicle

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-21. This information was provided to ClinicalTrials.gov by Turn Therapeutics on 2026-01-22.